@article{461e22eabd44477eb172901382f48929,
title = "Macular Hole Closure with Medical Treatment",
keywords = "Macular hole, Macular surgery, Vitreoretinal surgery",
author = "Sokol, \{Jared T.\} and Schechet, \{Sidney A.\} and Rahul Komati and Dean Eliott and Vavvas, \{Demetrios G.\} and Kaplan, \{Richard I.\} and Ittiara, \{Shaun T.\} and Farooq, \{Asim V.\} and Sheth, \{Veeral S.\} and MacCumber, \{Mathew W.\} and Rhona Ke and Gentile, \{Ronald C.\} and Dimitra Skondra",
note = "Funding Information: Disclosure(s): All authors have completed and submitted the ICMJE disclosures form. The author(s) have made the following disclosure(s): D.S.: Consultant - Allergan, Alimera Sciences, Biogen D.E.: Consultant - Alcon, Alimera Sciences, Allergan, Dutch Ophthalmic, Genentech, Regenxbio, Aldeyra Therapeutics; Financial support - NeurotechS.I.: Financial support - Allergan, Alimera SciencesR.C.G.: Financial support - Alcon Laboratories, Inc., Acucela, Genentech, GlaxoSmithKline, Notal Vision, Inc., Quark Pharmaceuticals, Regeneron Pharmaceuticals, Inc.Supported by the Juvenile Diabetes Research Foundation, New York, New York (R.C.G.); the National Eye Institute, National Institutes of Health, Bethesda, Maryland (R.C.G.); New York Eye and Ear Infirmary of Mount Sinai, New York, New York (R.C.G.); the University of Wisconsin, Madison, Wisconsin (R.C.G.); Diabetic Retinopathy Clinical Research Network, Tampa, Florida (R.C.G.). D.S.: Consultant - Allergan, Biogen, Alimera Sciences. Obtained funding: N/A",
year = "2021",
month = jul,
doi = "10.1016/j.oret.2020.11.018",
language = "English",
volume = "5",
pages = "711--713",
journal = "Ophthalmology Retina",
issn = "2468-6530",
publisher = "Elsevier Inc.",
number = "7",
}